Literature DB >> 12408952

Subclinical doses of the nerve gas sarin impair T cell responses through the autonomic nervous system.

Roma Kalra1, Shashi P Singh, Seddigheh Razani-Boroujerdi, Raymond J Langley, Walter B Blackwell, Rogene F Henderson, Mohan L Sopori.   

Abstract

The nerve gas sarin is a potent cholinergic agent, and exposure to high doses may cause neurotoxicity and death. Subclinical exposures to sarin have been postulated to contribute to the Gulf War syndrome; however, the biological effects of subclinical exposure are largely unknown. In this communication, evidence shows that subclinical doses (0.2 and 0.4 mg/m(3)) of sarin administered by inhalation to F344 rats for 1 h/day for 5 or 10 days inhibited the anti-sheep red blood cell antibody-forming cell response of spleen cells without affecting the distribution of lymphocyte subpopulations in the spleen. Moreover, sarin suppressed T cell responses, including the concanavalin A (Con A) and the anti-alphabeta-T cell receptor (TCR) antibody-induced T cell proliferation and the rise in the intracellular calcium following TCR ligation. These concentrations of sarin altered regional but not total brain acetylcholinesterase activity. Interestingly, serum corticosterone levels of the sarin-treated animals were dramatically lower than the control animals, indicating that sarin-induced immunosuppression did not result from the activation of the hypothalamus-pituitary-adrenal (HPA) axis. Pretreatment of animals with the ganglionic blocker chlorisondamine abrogated the inhibitory effects of sarin on spleen cell proliferation in response to Con A and anti-TCR antibodies. These results suggest that the effects of sarin on T cell responsiveness are mediated via the autonomic nervous system and are independent of the HPA axis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408952

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  9 in total

1.  Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice.

Authors:  Michael S Petrik; Margaret C Wong; Rena C Tabata; Robert F Garry; Christopher A Shaw
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

Review 2.  Healthcare utilization and mortality among veterans of the Gulf War.

Authors:  Gregory C Gray; Han K Kang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-04-29       Impact factor: 6.237

3.  All-Cause Mortality Among US Veterans of the Persian Gulf War: 13-Year Follow-up.

Authors:  Shannon K Barth; Han K Kang; Tim Bullman
Journal:  Public Health Rep       Date:  2016-10-27       Impact factor: 2.792

4.  Mortality in US Army Gulf War veterans exposed to 1991 Khamisiyah chemical munitions destruction.

Authors:  Tim A Bullman; Clare M Mahan; Han K Kang; William F Page
Journal:  Am J Public Health       Date:  2005-08       Impact factor: 9.308

5.  Trends in brain cancer mortality among U.S. Gulf War veterans: 21 year follow-up.

Authors:  Shannon K Barth; Erin K Dursa; Robert M Bossarte; Aaron I Schneiderman
Journal:  Cancer Epidemiol       Date:  2017-08-04       Impact factor: 2.984

Review 6.  Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review.

Authors:  Mohamed B Abou-Donia; Briana Siracuse; Natasha Gupta; Ashly Sobel Sokol
Journal:  Crit Rev Toxicol       Date:  2016-10-05       Impact factor: 5.635

7.  Inhalation of the nerve gas sarin impairs ventilatory responses to hypercapnia and hypoxia in rats.

Authors:  Jianguo Zhuang; Fadi Xu; Matthew J Campen; Cancan Zhang; Juan C Pena-Philippides; Mohan L Sopori
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-28       Impact factor: 4.219

Review 8.  Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.

Authors:  C A Shaw; L Tomljenovic
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 9.  Acetylcholinesterase inhibitor exposures as an initiating factor in the development of Gulf War Illness, a chronic neuroimmune disorder in deployed veterans.

Authors:  Lindsay T Michalovicz; Kimberly A Kelly; Kimberly Sullivan; James P O'Callaghan
Journal:  Neuropharmacology       Date:  2020-04-02       Impact factor: 5.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.